Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Zhuo-Yuan Lin"'
Autor:
Zhuo-yuan Lin, Guo Chen, Yan-qiong Zhang, Hui-chan He, Yu-xiang Liang, Jian-heng Ye, Ying-ke Liang, Ru-jun Mo, Jian-ming Lu, Yang-jia Zhuo, Yu Zheng, Fu-neng Jiang, Zhao-dong Han, Shu-lin Wu, Wei-de Zhong, Chin-Lee Wu
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-1 (2023)
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12943-017-0615-x.
Externí odkaz:
https://doaj.org/article/d042f4c5d6534ece87fd5ad57750dda9
Autor:
Zhuo-yuan Lin, Guo Chen, Yan-qiong Zhang, Hui-chan He, Yu-xiang Liang, Jian-heng Ye, Ying-ke Liang, Ru-jun Mo, Jian-ming Lu, Yang-jia Zhuo, Yu Zheng, Fu-neng Jiang, Zhao-dong Han, Shu-lin Wu, Wei-de Zhong, Chin-Lee Wu
Publikováno v:
Molecular Cancer, Vol 16, Iss 1, Pp 1-14 (2017)
Abstract Background Even though aberrant expression of microRNA (miR)-30d has been reported in prostate cancer (PCa), its associations with cancer progression remain contradictory. The aim of this study was to investigate clinical significance, biolo
Externí odkaz:
https://doaj.org/article/dafef72eefd84824ae9aabaaf94a8720
Autor:
Zhuo-yuan Lin, Guo Chen, Yan-qiong Zhang, Hui-chan He, Yu-xiang Liang, Jian-heng Ye, Ying-ke Liang, Ru-jun Mo, Jian-ming Lu, Yang-jia Zhuo, Yu Zheng, Fu-neng Jiang, Zhao-dong Han, Shu-lin Wu, Wei-de Zhong, Chin-Lee Wu
Publikováno v:
Molecular Cancer, Vol 18, Iss 1, Pp 1-2 (2019)
After publication of the article [1], the author reported that this article contained some errors.
Externí odkaz:
https://doaj.org/article/d0690d58a7594798b70a58449981c3ce
Autor:
Chaojiang Chen, Zhuo-yuan Lin, Yue-Ping Wan, Yangjia Zhuo, Funeng Jiang, Ze-Zhen Liu, Ming Xi, Xing Zhou, Yu Zheng, Zhiduan Cai, Jian-xin Li, Jianguo Zhu, Wei-de Zhong
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Cancer
BMC Cancer
Background Solute Carrier Family 6 Member 1 (SLC6A1) has been identified as a cancer-promoting gene in various human cancers, such as clear cell renal cell carcinoma and ovarian cancer. However, its roles in prostate cancer (PCa) has not been fully e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66db0a5a50f2668e1815ca90b153655e
http://link.springer.com/article/10.1186/s12885-020-06776-7
http://link.springer.com/article/10.1186/s12885-020-06776-7
Autor:
Yu-Xiang Liang, Ying-Ke Liang, Zhi-Hao Zou, Yang-Jia Zhuo, Jian-Heng Ye, Xue-Jin Zhu, Zhou-Da Cai, Zhuo-Yuan Lin, Ru-Jun Mo, Shu-Lin Wu, Yan-Qiong Zhang, Wei-De Zhong
Publikováno v:
Disease Markers.
Background. In our previous research, we developed a 32-gene risk index model that may be utilized as a robust prognostic method for predicting prostate cancer (PCa) recurrence after surgery. Among the 32 genes, the Fifth Ewing Variant (FEV) gene was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4acdc73f98cf3040e277463149a011
Autor:
Jianming Lu, Yingke Liang, Jie Zeng, Guohua Zeng, Chao Cai, Jiehui Zhong, Zezhen Liu, Weide Zhong, Qinwei Liu, Xin-Yuan Sun, Zhuo-yuan Lin, Xiaolu Duan, Wenzheng Wu
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
The aim of this study was to elucidate the correlation between m6A modification and the tumor immune microenvironment (TIME) in prostate cancer (PCa) and to identify the m6A regulation patterns suitable for immune checkpoint inhibitors (ICIs) therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4e03c9ae0ca84f811d23bdfe921d733
https://doi.org/10.3389/fimmu.2021.735170
https://doi.org/10.3389/fimmu.2021.735170
Autor:
Song Wan, Zhiduan Cai, Yingke Liang, Ru-Jun Mo, Jun-Xu Chen, Weide Zhong, Zhuo-yuan Lin, Ze-Zhen Liu, Zhao-Dong Han, Yulin Deng, Hui-chan He, Yangjia Zhuo
Publikováno v:
Cellular Signalling. 59:152-162
Immunotherapy has made great breakthroughs in the field of cancer. However, the immunotherapeutic effect of prostate cancer is unsatisfactory. We found that the expression of TRIB1 was significantly correlated with the infiltration of CD163+ macropha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00884819dc90b1b3eb50fe868cb32b9a
https://doi.org/10.1016/j.cellsig.2019.03.017
https://doi.org/10.1016/j.cellsig.2019.03.017
Autor:
Yu-Xiang, Liang, Ying-Ke, Liang, Zhi-Hao, Zou, Yang-Jia, Zhuo, Jian-Heng, Ye, Xue-Jin, Zhu, Zhou-Da, Cai, Zhuo-Yuan, Lin, Ru-Jun, Mo, Shu-Lin, Wu, Yan-Qiong, Zhang, Wei-De, Zhong
Publikováno v:
Disease markers. 2022
In our previous research, we developed a 32-gene risk index model that may be utilized as a robust prognostic method for predicting prostate cancer (PCa) recurrence after surgery. Among the 32 genes, the Fifth Ewing Variant (FEV mRNA expression was a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::455d2a22be44cba7de01f479cd4e01ed
https://pubmed.ncbi.nlm.nih.gov/35548776
https://pubmed.ncbi.nlm.nih.gov/35548776
Publikováno v:
Biochemistry and cell biology = Biochimie et biologie cellulaire. 98(3)
Prostate cancer (PCa) is the second leading cause of death in men, and current studies have shown that circular RNAs (circRNAs) play important roles in its occurrence and development. Detection of circRNAs in PCa cells showed that circ_KATNAL1 is dow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70e3b494a32c3c3dd8b39131c903631b
https://pubmed.ncbi.nlm.nih.gov/31800303
https://pubmed.ncbi.nlm.nih.gov/31800303
Autor:
Zhuo-yuan Lin1,2, Guo Chen1, Yan-qiong Zhang3,4,5, Hui-chan He1, Yu-xiang Liang1, Jian-heng Ye1,4,5, Ying-ke Liang1,6, Ru-jun Mo1,6, Jian-ming Lu1,6, Yang-jia Zhuo1,6, Yu Zheng2,6, Fu-neng Jiang2,6, Zhao-dong Han1, Shu-lin Wu1, Wei-de Zhong1,6,7,8 zhongwd2009@live.cn, Chin-Lee Wu1,4,5 cwu2@mgh.harvard.edu
Publikováno v:
Molecular Cancer. 2/27/2017, Vol. 16, p1-14. 14p. 1 Diagram, 1 Chart, 5 Graphs.